Home » Pfizer » Morgan Stanley lowers Pfizer (NYSE:PFE) price target from $39 to $37 Morgan Stanley lowers Pfizer (NYSE:PFE) price target from $39 to $37 Posted on November 1, 2023 By legume No Comments on Morgan Stanley lowers Pfizer (NYSE:PFE) price target from $39 to $37 Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $39 to $37. Health Care Tags:Pfizer